The share price of Krystal Biotech, Inc. (KRYS) now
What analysts predict: $152.18
52-week High/Low: $132.68 / $69.81
50/200 Day Moving Average:
$111.65 / $105.43
This figure corresponds to the Average Price over the previous 50/200 days.
For Krystal Biotech stocks, the 50-day moving average is the resistance level today.
For Krystal Biotech stocks, the 200-day moving average is the support level today.
Are you interested in Krystal Biotech, Inc. stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the Krystal Biotech
stock price in 2023, 2024, 2025, 2026, 2027.
How much will one Krystal Biotech share be worth in
2023 - 2027?
When should I take profit in Krystal Biotech stock?
When should I record a loss on Krystal Biotech stock?
What are analysts' forecasts for Krystal Biotech stock?
What is the future of Krystal Biotech stock?
We forecast Krystal Biotech stock performance using neural networks based on historical data on Krystal Biotech stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Krystal Biotech stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2023, 2024, 2025, 2026 and 2027)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Krystal Biotech shares. This happens once a day.
Historical and forecast chart of Krystal Biotech stock
The chart below shows the historical price of Krystal Biotech stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Krystal Biotech stock price can be found in the table below.
Long-term forecasts by years.
Krystal Biotech is a clinical gene therapy drug manufacturer committed to creating and marketing advanced therapies for skin patients. The company has developed and patented a gene therapy platform that enables the development of ready-to-use treatments for skin conditions that cannot be cured with known methods.
Trending Themes in the Healthcare Sector
Krystal Biotech daily forecast for a month
Date
Target
Pes.
Opt.
Vol., %
Dec 05
111.46
110.08
114.85
4.33
Dec 06
113.42
111.43
115.33
3.50
Dec 07
109.98
106.94
113.32
5.97
Dec 08
106.76
105.10
109.45
4.14
Dec 09
105.18
101.90
108.04
6.03
Dec 10
109.35
107.91
110.62
2.51
Dec 11
108.78
107.65
110.22
2.38
Dec 12
107.56
105.45
109.80
4.12
Dec 13
110.75
108.31
112.74
4.09
Dec 14
107.91
105.88
110.54
4.40
Dec 15
105.36
103.93
106.63
2.59
Dec 16
107.35
104.55
109.49
4.72
Dec 17
109.19
106.18
111.46
4.98
Dec 18
109.58
108.71
111.03
2.14
Dec 19
108.27
106.93
109.66
2.55
Dec 20
110.30
109.33
112.64
3.03
Dec 21
108.19
106.76
109.66
2.72
Dec 22
109.23
106.87
111.89
4.70
Dec 23
106.78
105.92
108.70
2.62
Dec 24
108.06
106.76
110.44
3.44
Dec 25
109.62
107.73
111.28
3.30
Dec 26
111.50
108.11
114.49
5.90
Dec 27
110.61
107.25
114.11
6.39
Dec 28
111.05
108.48
112.70
3.89
Dec 29
110.47
108.53
111.89
3.09
Dec 30
109.28
106.75
112.78
5.65
Dec 31
108.49
107.37
110.58
2.99
Jan 01
108.10
107.11
110.96
3.59
Jan 02
109.01
107.70
112.46
4.41
Jan 03
110.23
107.46
112.39
4.60
Krystal Biotech Daily Price Targets
Krystal Biotech Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $111.46. Positive dynamics for Krystal Biotech shares will prevail with possible volatility of 4.154%. Pessimistic target level: 110.08 Optimistic target level: 114.85
Krystal Biotech Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $113.42. Positive dynamics for Krystal Biotech shares will prevail with possible volatility of 3.383%. Pessimistic target level: 111.43 Optimistic target level: 115.33
Krystal Biotech Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $109.98. Negative dynamics for Krystal Biotech shares will prevail with possible volatility of 5.629%. Pessimistic target level: 106.94 Optimistic target level: 113.32
Krystal Biotech Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $106.76. Negative dynamics for Krystal Biotech shares will prevail with possible volatility of 3.980%. Pessimistic target level: 105.10 Optimistic target level: 109.45
Krystal Biotech Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $105.18. Negative dynamics for Krystal Biotech shares will prevail with possible volatility of 5.685%. Pessimistic target level: 101.90 Optimistic target level: 108.04
Krystal Biotech Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $109.35. Positive dynamics for Krystal Biotech shares will prevail with possible volatility of 2.452%. Pessimistic target level: 107.91 Optimistic target level: 110.62
2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, US
Market Capitalization:
2 839 246 000 $
Market capitalization of the Krystal Biotech, Inc. is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of KRYS shares in the company outstanding by the market price of one share.
EBITDA:
-131 810 000 $
EBITDA of Krystal Biotech is earnings before interest, income tax and depreciation of assets.
PE Ratio:
None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
None
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
-1.17
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
N/A
Quarterly Revenue Growth YOY:
N/A
Trailing PE:
-
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
-
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
-
Enterprise Value (EV) /Revenue
EV To EBITDA:
-11.46
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
28206300
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website